MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 527862 | Name: CL-55

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CL-55 is a novel T3SS inhibitor; Antichlamydial agent.

Chemical Structure

CL-55
CL-55
CAS#1370706-59-4

Theoretical Analysis

MedKoo Cat#: 527862

Name: CL-55

CAS#: 1370706-59-4

Chemical Formula: C19H17F2N3O4S

Exact Mass: 421.0908

Molecular Weight: 421.42

Elemental Analysis: C, 54.15; H, 4.07; F, 9.02; N, 9.97; O, 15.19; S, 7.61

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
CL-55; CL 55; CL55
IUPAC/Chemical Name
4-(3-Ethoxy-4-hydroxy-benzyl)-5-oxo-5,6-dihydro-4H-[1,3,4]thiadiazine-2-carboxylic acid (2,4-difluoro-phenyl)-amide
InChi Key
DAKWAZGLXWXDBB-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H17F2N3O4S/c1-2-28-16-7-11(3-6-15(16)25)9-24-17(26)10-29-19(23-24)18(27)22-14-5-4-12(20)8-13(14)21/h3-8,25H,2,9-10H2,1H3,(H,22,27)
SMILES Code
O=C(C(SC1)=NN(CC2=CC=C(O)C(OCC)=C2)C1=O)NC3=CC=C(F)C=C3F
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 421.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Nesterenko LN, Zigangirova NA, Zayakin ES, Luyksaar SI, Kobets NV, Balunets DV, Shabalina LA, Bolshakova TN, Dobrynina OY, Gintsburg AL. A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones suppresses Salmonella infection in vivo. J Antibiot (Tokyo). 2016 Jun;69(6):422-7. doi: 10.1038/ja.2015.131. Epub 2016 Jan 6. PubMed PMID: 26732253. 2: Zohrevandi B, Monsef Kasmaie V, Asadi P, Tajik H, Azizzade Roodpishi N. Diagnostic Accuracy of Cincinnati Pre-Hospital Stroke Scale. Emerg (Tehran). 2015 Summer;3(3):95-8. PubMed PMID: 26495392; PubMed Central PMCID: PMC4608338. 3: Zigangirova NA, Kost EA, Didenko LV, Kapotina LN, Zayakin ES, Luyksaar SI, Morgunova EY, Fedina ED, Artyukhova OA, Samorodov AV, Kobets NV. A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones inhibits intracellular growth and persistence of Chlamydia trachomatis. J Med Microbiol. 2016 Jan;65(1):91-8. PubMed PMID: 26489840. 4: Koroleva EA, Kobets NV, Zayakin ES, Luyksaar SI, Shabalina LA, Zigangirova NA. Small molecule inhibitor of type three secretion suppresses acute and chronic Chlamydia trachomatis infection in a novel urogenital Chlamydia model. Biomed Res Int. 2015;2015:484853. doi: 10.1155/2015/484853. Epub 2015 Jan 28. PubMed PMID: 25695086; PubMed Central PMCID: PMC4324818. 5: Abbouda A, Restivo L, Bruscolini A, Pirraglia MP, De Marco F, La Cava M, Pivetti Pezzi P. Contact Lens Care among Teenage Students in Italy: A Cross-Sectional Study. Semin Ophthalmol. 2016;31(3):226-32. doi: 10.3109/08820538.2014.962155. Epub 2014 Oct 9. PubMed PMID: 25299394. 6: Gao M, Huang Q, Chu Y, Ding C, Zhang B, Su X. Analysis of the leaf methylomes of parents and their hybrids provides new insight into hybrid vigor in Populus deltoides. BMC Genet. 2014;15 Suppl 1:S8. doi: 10.1186/1471-2156-15-S1-S8. Epub 2014 Jun 20. PubMed PMID: 25080097; PubMed Central PMCID: PMC4118634. 7: Kow AW, Wook CD, Song SC, Kim WS, Kim MJ, Park HJ, Heo JS, Choi SH. Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution. World J Surg. 2012 May;36(5):1112-21. doi: 10.1007/s00268-012-1497-0. PubMed PMID: 22374541. 8: Renner L, Prin M, Li FY, Goka B, Northrup V, Paintsil E. Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana. AIDS Res Treat. 2011;2011:896040. doi: 10.1155/2011/896040. Epub 2011 May 11. PubMed PMID: 21738861; PubMed Central PMCID: PMC3124224. 9: Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. J Am Acad Dermatol. 2010 Jul;63(1):52-62. doi: 10.1016/j.jaad.2009.07.052. Epub 2010 May 21. PubMed PMID: 20488582. 10: Hammerstingl C, Omran H, Tripp C, Poetzsch B. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study. Thromb Haemost. 2009 Feb;101(2):325-32. PubMed PMID: 19190817. 11: Li W, Gao J, Zhao HZ, Liu CX. Development of a HPLC-UV assay for silybin-phosphatidylcholine complex (silybinin capsules) and its pharmacokinetic study in healthy male Chinese volunteers. Eur J Drug Metab Pharmacokinet. 2006 Oct-Dec;31(4):265-70. PubMed PMID: 17315537. 12: Velasque LS, Estrela RC, Suarez-Kurtz G, Struchiner CJ. A new model for the population pharmacokinetics of didanosine in healthy subjects. Braz J Med Biol Res. 2007 Jan;40(1):97-104. PubMed PMID: 17225002. 13: Velasque LS, Estrela Rde C, Suarez-Kurtz G, Struchiner CJ. Estimating the genetic component (RGC) in pharmacokinetic variability of the antiretroviral didanosine among healthy Brazilians. AIDS. 2005 Oct;19 Suppl 4:S76-80. PubMed PMID: 16249659. 14: Scheepe JR, Vis AN, Mickisch GH. Recurrence after radical prostatectomy for organ-confined prostate cancer. Onkologie. 2003 Aug;26(4):330-3. PubMed PMID: 12972697. 15: Ren K. An improved method for assessing mechanical allodynia in the rat. Physiol Behav. 1999 Nov;67(5):711-6. PubMed PMID: 10604842. 16: Okada J, Kobayashi N, Taniguchi K, Urasawa S. Analysis on reassortment of rotavirus NSP1 genes lacking coding region for cysteine-rich zinc finger motif. Arch Virol. 1999;144(2):345-53. PubMed PMID: 10470258. 17: Frencken JE, Makoni F, Sithole WD, Hackenitz E. Three-year survival of one-surface ART restorations and glass-ionomer sealants in a school oral health programme in Zimbabwe. Caries Res. 1998;32(2):119-26. PubMed PMID: 9544860. 18: Schønheyder HC, Henriques U. Postmortem blood cultures. Evaluation of separate sampling of blood from the right and left cardiac ventricle. APMIS. 1997 Jan;105(1):76-8. PubMed PMID: 9063505. 19: Parodi B, Esposito M, Viale M, Cafaggi S, Vannozzi M. Chemical and biological properties of a new cis-diammineplatinum (II) complex containing para-aminobenzoic acid as amino ligand. Anticancer Res. 1995 May-Jun;15(3):895-9. PubMed PMID: 7645978. 20: A multicenter study of colorectal adenomas. Rationale, objectives, methods and characteristics of the study cohort. The Multicentric Study of Colorectal Adenomas (SMAC) Workgroup. Tumori. 1995 May-Jun;81(3):157-63. PubMed PMID: 7571020.